BuzzSparks.org

NovImmune


Therapeutic monoclonal antibodies

NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.

Founded in 1998
Homepage:
Total money raised: $155.4M

Geneva